
Prof. Andrea Forschner (DO), and Dr. Shaheer Ahmad Khan (MD), break down other data in metastatic uveal melanoma from the 2025 ESMO Congress.

Your AI-Trained Oncology Knowledge Connection!


Prof. Andrea Forschner (DO), and Dr. Shaheer Ahmad Khan (MD), break down other data in metastatic uveal melanoma from the 2025 ESMO Congress.

Prof. Andrea Forschner (DO), and Dr. Shaheer Ahmad Khan (MD), discuss other ways percutaneous hepatic perfusion could be integrated into metastatic uveal melanoma management.

Prof. Andrea Forschner (DO), and Dr. Shaheer Ahmad Khan (MD), discuss the potential clinical implications of the CHOPIN trial in metastatic uveal melanoma.

Prof. Andrea Forschner (DO), and Dr. Shaheer Ahmad Khan (MD), break down data from the phase 2 CHOPIN trial evaluating percutaneous hepatic perfusion plus nivolumab and ipilimumab in metastatic uveal melanoma.

Prof. Andrea Forschner (DO), and Dr. Shaheer Ahmad Khan (MD), discuss the use of percutaneous hepatic perfusion in metastatic uveal melanoma.

Prof. Andrea Forschner (DO), and Dr. Shaheer Ahmad Khan (MD), highlight current treatment approaches in metastatic uveal melanoma.

Prof. Andrea Forschner (DO), and Dr. Shaheer Ahmad Khan (MD), explore potential future research directions in metastatic uveal melanoma.

Published: December 23rd 2025 | Updated:

Published: December 9th 2025 | Updated:

Published: December 23rd 2025 | Updated:

Published: December 16th 2025 | Updated:

Published: January 8th 2025 | Updated:

Published: December 16th 2025 | Updated: